GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Z

Zepp Health ZEPP · USD

Information Technology · US listing · 🇺🇸 United States

Compare

2.35

+4.44%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

7 analysts, 1 Nov 2026. The analysts' own views, not ours.

  • 2Strong buy
  • 4Buy
  • 1Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Nov 2026. Not our view.

Low
12.00
Average
12.00
Median
12.00
High
12.00

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027
Revenue$2.26bn$2.66bn
Revenue, highest$2.26bn$2.66bn
Revenue, lowest$2.26bn$2.66bn
Analysts11

Earnings against forecasts

Earnings per share by fiscal quarter

Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023
Forecast0.230.170.020.170.40
Reported-1.40-0.78-0.600.040.01
Difference-715.1%-570.4%-2664.1%-76.3%-98.6%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

4 / 10

Revenue growth 7.0% a year over 10 years. Return on equity -18.7%.

Model fair value

28.35

From earnings 28.35, from revenue 152.62.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.